Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock an... ( SEATTLE April 28 2011 /- Cell Therape...)

HOME >> MEDICINE >> TECHNOLOGY

Cell Therapeutics, Inc. Announces Institutional Investors Purchase Approximately $16.0 Million of Preferred Stock and Warrants

Date:4/27/2011

SEATTLE, April 28, 2011 /PRNewswire/ -- Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell, subject to customary closing conditions, approximately $16.0 million of shares of its Series 12 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to three institutional investors. Each share of Series 12 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 2,857 shares of common stock at a conversion price of $0.35 per share of common stock, for a total of 45,634,286 shares of common stock.

In connection with the offering, the investors received warrants to purchase up to 18,253,714 shares of common stock. The warrants have an exercise price of $0.40 per warrant share, for total potential additional proceeds to the Company of approximately $7.3 million upon exercise of the warrants for cash. The warrants are exercisable immediately and expire five years from the date of issuance.

The Company intends to use the net proceeds from the offering for general corporate purposes, which may include, among other things, paying interest on and/or retiring portions of its outstanding debt, funding research and development, preclinical and clinical trials, the preparation and filing of new drug applications and general working capital. The Company may also use a portion of the net proceeds to fund possible investments in, or acquisitions of, complementary businesses, technologies or products. The Company has recently engaged in limited discussions with third parties regarding such investments or acquisitions, but has no current agreements or commitments with respect to any investment or acquisition.

Shares of the Series 12 Preferred Stock will receive dividends in the same amount as any dividends declared and paid on shares of common stock and have no voting ri
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/22/2013)... HARRISON, N.Y. , May 22, 2013 MGT ... the Company will present at the Second Annual Marcum ... New York City at the ... President and Chief Executive Officer, will update investors and ... The Company,s presentation is scheduled to begin ...

(Date:5/22/2013)... and TORONTO , May 22, 2013 ... today announced three presentations demonstrating the superiority of the ... subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ). The presentations ... American Society of Clinical Oncology (ASCO) to be held ... through June 4, 2013. The presentation entitled ...

(Date:5/22/2013)... May 22, 2013 Grifols, a global healthcare company ... results from a study demonstrating that a higher dose ... increased levels of the alpha 1 protein in ... that are considered within the normal range for healthy ... which low levels of the alpha 1 proteinase ...

Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3 MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3 Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4

[0] MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference [0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine [0] Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency

... 8, 2011 Elekta has collaborated with the National ... Practice Guidelines in Oncology ( NCCN Guidelines ™) into ... users real-time access to NCCN,s evidence-based clinical content directly ... " The NCCN Guidelines are widely ...

... PARK, Calif., June 8, 2011 ForteBio®, Inc., ... the development of biotherapeutic and pharmaceutical products, today ... Anti-Mouse IgG Fc Capture (AMC) biosensor for use ... biosensor enables high-throughput rapid kinetic characterization and screening ...

Cached Medicine Technology:National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR 2 ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies 2

National Comprehensive Cancer Network Guidelines Available in Elekta's MOSAIQ EMR ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies

(Date:5/22/2013)... Cedar Rapids, IA (PRWEB) May 22, 2013 ... inspirational theatre piece Handicap This! The performance promotes ... pursuing their dreams. The Handicap This! performance will be ... Linn Mar High School auditorium. Tickets for Handicap ... , Handicap This! helps audiences measure the level to ...

(Date:5/22/2013)... Twenty student-led startup companies at Arizona ... an intensive startup accelerator designed to help them execute ... create local jobs as part of ASU’s Edson ... initiative offers approximately 20 student teams up to $20,000 ... to launch their for-profit, more-than-profit or nonprofit ventures. The ...

(Date:5/22/2013)... ANN ARBORA University of Michigan study challenges previous ... League Baseball. , The study, a collaboration between ... and Florida, looks deeper into the controversial argument ... more strikes for pitchers of the same race. ... claim, said Jason Winfree, associate professor of sport ...

(Date:5/22/2013)... 22 (HealthDay News) -- Over the next two decades, ... is expected to more than double, topping more than ... The main factor driving the increase: an aging population. ... the American Stroke Association, was published May 22 in ... strain the health care system," Dr. Bruce Ovbiagele, chairman ...

(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...

[0] Handicap This! Comes to Marion, Iowa [0] ASU Announces Edson Student Entrepreneur Initiative’s 2013-2014 Cohort [0] U-M study challenges notion that umpires call more strikes for pitchers of same race [0] Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report [0] Hospitals profit when patients develop bloodstream infections

... Fall, September 22, Focuses on Preventing Falls to ... issued,another call to action urging government, citizens and ... increasing number of falls,among people 65 years of ... Enzi (R-WY), as well as Representatives Frank Pallone ...

... Brookstone donates portion of sales of popular pink, ... Awareness Month, MIAMI BEACH, Fla., Sept. 22 ... have teamed up to provide,support for women diagnosed with ... of Breast Cancer Awareness Month., Through the ,Dash ...

... Partnership with AMICAS will enable practice,s strategic ... AMICAS, Inc. (Nasdaq: AMCS ),a leader ... management,solutions, today announced a new partnership with ... Medical Diagnostic Imaging Group (MDIG) of,Phoenix, AZ. ...

... Sept. 22 University of Pittsburgh scientists are uncovering more ... of Merkel cell carcinoma, an aggressive and deadly form of ... online edition of the Proceedings of the National Academy ... infects tumors that already have formed. If that were the ...

... SPECT Procedures ... ASNC Technology Standards, POWAY, Calif., Sept. 22 Digirad ... systems and,services to physicians, offices, hospitals and other medical services,providers, ... (FDA) 510(k) clearance for its new nSPEED(R) reconstruction,software -- for ...

... to Enhance Computer Security, ATLANTA, Sept. 22 ... providers, has published the locations,of the computers, from ... against its clients in 2008. The United States ... from computers within the,country and China ran second ...

Cached Medicine News:Health News:Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day 2 Health News:Nonprofit Charity for Women and Brookstone Dash to Fund Breast Cancer Support 2 Health News:Medical Diagnostic Imaging Group Chooses AMICAS 2 Health News:Medical Diagnostic Imaging Group Chooses AMICAS 3 Health News:Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer 2 Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 2 Health News:Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation 3 Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 2 Health News:Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data 3

Home Safety Council(R) Applauds Creation of Falls Prevention Awareness Day Nonprofit Charity for Women and Brookstone Dash to Fund Breast Cancer Support Medical Diagnostic Imaging Group Chooses AMICAS Pitt research indicates new virus is culprit, not bystander, in deadly skin cancer Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation Compromised US and Chinese Computers Launch Greatest Number of Cyber Attacks, According to SecureWorks' Data

The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...

The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...

The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...

The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...

Medicine Products:

Zeiss Z-55 Style Surgical Microscope Video Adapter from ImagingPlanet Leica L-80 Style Surgical Microscope Video Adapter from ImagingPlanet Zeiss® Z-80 Style Surgical Microscope Adapter from ImagingPlanet Zeiss® Z-55 Style Surgical Microscope Adapter from ImagingPlanet